why choose us

First received: July 15, 2023

Clinical Trial: Empagliflozin in Heart Failure Dialysis Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of Empagliflozin on Heart Failure Dialysis Patients

Brief Summary: Empagliflozin is not still approved for glomerular filtration rate < 20 cc/min/1.73m2.Considering the cardiac and renal benefits of this drug, the evaluation of the safety and efficacy of Empagliflozin for heart failure dialysis patients seems to be mandatory.

Read more